Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function - PubMed (original) (raw)
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function
A A Kocher et al. Nat Med. 2001 Apr.
Abstract
Left ventricular remodeling is a major cause of progressive heart failure and death after myocardial infarction. Although neoangiogenesis within the infarcted tissue is an integral component of the remodeling process, the capillary network is unable to support the greater demands of the hypertrophied myocardium, resulting in progressive loss of viable tissue, infarct extension and fibrous replacement. Here we show that bone marrow from adult humans contains endothelial precursors with phenotypic and functional characteristics of embryonic hemangioblasts, and that these can be used to directly induce new blood vessel formation in the infarct-bed (vasculogenesis) and proliferation of preexisting vasculature (angiogenesis) after experimental myocardial infarction. The neoangiogenesis resulted in decreased apoptosis of hypertrophied myocytes in the peri-infarct region, long-term salvage and survival of viable myocardium, reduction in collagen deposition and sustained improvement in cardiac function. The use of cytokine-mobilized autologous human bone-marrow-derived angioblasts for revascularization of infarcted myocardium (alone or in conjunction with currently used therapies) has the potential to significantly reduce morbidity and mortality associated with left ventricular remodeling.
Comment in
- Helping the heart to heal with stem cells.
Rosenthal N, Tsao L. Rosenthal N, et al. Nat Med. 2001 Apr;7(4):412-3. doi: 10.1038/86472. Nat Med. 2001. PMID: 11283662 No abstract available.
Similar articles
- Myocardial neovascularization by adult bone marrow-derived angioblasts: strategies for improvement of cardiomyocyte function.
Itescu S, Kocher AA, Schuster MD. Itescu S, et al. Ann Hematol. 2002;81 Suppl 2:S21-5. Ann Hematol. 2002. PMID: 12611063 Review. - Downregulation of the CXC chemokine receptor 4/stromal cell-derived factor 1 pathway enhances myocardial neovascularization, cardiomyocyte survival, and functional recovery after myocardial infarction.
Bonaros N, Sondermeijer H, Wiedemann D, Schlechta B, Schachner T, Schuster M, Seki T, Martens TP, Itescu S, Kocher AA. Bonaros N, et al. J Thorac Cardiovasc Surg. 2011 Sep;142(3):687-96, 696.e1-2. doi: 10.1016/j.jtcvs.2011.01.014. Epub 2011 Mar 8. J Thorac Cardiovasc Surg. 2011. PMID: 21388641 - Myocardial homing and neovascularization by human bone marrow angioblasts is regulated by IL-8/Gro CXC chemokines.
Kocher AA, Schuster MD, Bonaros N, Lietz K, Xiang G, Martens TP, Kurlansky PA, Sondermeijer H, Witkowski P, Boyle A, Homma S, Wang SF, Itescu S. Kocher AA, et al. J Mol Cell Cardiol. 2006 Apr;40(4):455-64. doi: 10.1016/j.yjmcc.2005.11.013. Epub 2006 Jan 24. J Mol Cell Cardiol. 2006. PMID: 16438981 - New directions in strategies using cell therapy for heart disease.
Itescu S, Schuster MD, Kocher AA. Itescu S, et al. J Mol Med (Berl). 2003 May;81(5):288-96. doi: 10.1007/s00109-003-0432-0. Epub 2003 Apr 16. J Mol Med (Berl). 2003. PMID: 12698252 Review. - Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction.
Iwasaki H, Kawamoto A, Ishikawa M, Oyamada A, Nakamori S, Nishimura H, Sadamoto K, Horii M, Matsumoto T, Murasawa S, Shibata T, Suehiro S, Asahara T. Iwasaki H, et al. Circulation. 2006 Mar 14;113(10):1311-25. doi: 10.1161/CIRCULATIONAHA.105.541268. Circulation. 2006. PMID: 16534028
Cited by
- Homing of stem cells to ischemic myocardium.
Taghavi S, George JC. Taghavi S, et al. Am J Transl Res. 2013 May 24;5(4):404-11. Print 2013. Am J Transl Res. 2013. PMID: 23724164 Free PMC article. - Cell-based interventions for therapeutic angiogenesis: review of potential cell sources.
Brenes RA, Bear M, Jadlowiec C, Goodwin M, Hashim P, Protack CD, Ziegler KR, Li X, Model LS, Lv W, Collins MJ, Dardik A. Brenes RA, et al. Vascular. 2012 Dec;20(6):360-8. doi: 10.1258/vasc.2011.201205. Epub 2012 Oct 19. Vascular. 2012. PMID: 23086985 Free PMC article. Review. - Does pretreatment of bone marrow mesenchymal stem cells with 5-azacytidine or double intravenous infusion improve their therapeutic potential for dilated cardiomyopathy?
Yang S, Piao J, Jin L, Zhou Y. Yang S, et al. Med Sci Monit Basic Res. 2013 Jan 14;19:20-31. doi: 10.12659/msmbr.883737. Med Sci Monit Basic Res. 2013. PMID: 23314418 Free PMC article. - A novel autologous cell-based therapy to promote diabetic wound healing.
Castilla DM, Liu ZJ, Tian R, Li Y, Livingstone AS, Velazquez OC. Castilla DM, et al. Ann Surg. 2012 Oct;256(4):560-72. doi: 10.1097/SLA.0b013e31826a9064. Ann Surg. 2012. PMID: 22964729 Free PMC article. - Revisiting cardiovascular regeneration with bone marrow-derived angiogenic and vasculogenic cells.
Lee S, Yoon YS. Lee S, et al. Br J Pharmacol. 2013 May;169(2):290-303. doi: 10.1111/j.1476-5381.2012.01857.x. Br J Pharmacol. 2013. PMID: 22250888 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources